Miri Shahnaz, Moghekar Abhay, Carey Andrew R, Gailloud Phillipe, Miller Neil R
Department of Ophthalmology, Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD, United States.
Departments of Neurology and Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, MD, United States.
Front Ophthalmol (Lausanne). 2022 Jun 20;2:923092. doi: 10.3389/fopht.2022.923092. eCollection 2022.
Idiopathic intracranial hypertension (IIH) has an increasing incidence worldwide over the past decade, with a high economic burden on patients and society. Up to 10% of patients with IIH have progressive visual decline requiring an invasive intervention (including cerebrospinal fluid shunting, cerebral dural sinus stenting, or optic nerve sheath fenestration [ONSF]). IIH patients with visual decline usually undergo evaluation and initial management through the emergency department (ED) and commonly have a long hospital stay due to the lack of a dedicated methodology for evaluation and management, particularly in patients who present with visual loss (i.e., fulminant IIH). An innovative practice approach is needed to improve the means of multidisciplinary communication in care and evaluation of IIH patients. This paper aims to discuss the need for the development and implementation of a multidisciplinary "fast-track" strategy for the evaluation and management of patients with fulminant IIH or those with a suboptimal response to maximum tolerated medical treatment at risk for visual loss. We suggest that such a program could reduce hospital stay and ED visits and therefore reduce healthcare costs and improve patient outcomes by accelerating the management process.
在过去十年中,特发性颅内高压(IIH)在全球的发病率呈上升趋势,给患者和社会带来了沉重的经济负担。高达10%的IIH患者会出现进行性视力下降,需要进行侵入性干预(包括脑脊液分流、硬脑膜窦支架置入或视神经鞘开窗术[ONSF])。视力下降的IIH患者通常通过急诊科(ED)进行评估和初始治疗,由于缺乏专门的评估和治疗方法,尤其是那些出现视力丧失的患者(即暴发性IIH),他们通常住院时间较长。需要一种创新的实践方法来改善IIH患者护理和评估中的多学科沟通方式。本文旨在探讨为暴发性IIH患者或对最大耐受药物治疗反应欠佳且有视力丧失风险的患者制定和实施多学科“快速通道”评估和管理策略的必要性。我们认为,这样一个项目可以通过加快管理流程来缩短住院时间和减少急诊科就诊次数,从而降低医疗成本并改善患者预后。